A PHP Error was encountered

Severity: Warning

Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests

Filename: helpers/my_audit_helper.php

Line Number: 176

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 1034
Function: getPubMedXML

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3152
Function: GetPubMedArticleOutput_2016

File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global

File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword

File: /var/www/html/index.php
Line: 316
Function: require_once

RATE OF INFECTION (TUBERCULOSIS) IN BRAZILIANS IBD PRIVATE PATIENTS: FOLLOW-UP 15 YEARS. | LitMetric

RATE OF INFECTION (TUBERCULOSIS) IN BRAZILIANS IBD PRIVATE PATIENTS: FOLLOW-UP 15 YEARS.

Arq Gastroenterol

Universidade Uniderp, Faculdade de Medicina, Campo Grande, MS, Brasil.

Published: March 2024

AI Article Synopsis

  • Latent tuberculosis (LTB) is an infection caused by Mycobacterium tuberculosis that can activate into active TB, especially after patients undergo biological therapy for inflammatory bowel diseases (IBD).
  • A 15-year retrospective study in Brazil assessed LTB risks among IBD patients, showing that factors like age, gender, and usage of specific medications (adalimumab and infliximab) significantly increased LTB incidence.
  • The findings emphasize the need for continuous monitoring of IBD patients on anti-TNF therapies, as prolonged exposure raises the risk of developing LTB.

Article Abstract

Background: Latent tuberculosis (LTB) is a condition where the patient is infected with Mycobacterium tuberculosis but does not develop active TB. There's a possibility of tuberculosis (TB) activation following the introduction of anti-TNFs.

Objective: To assess the risk of biological therapy inducing LTB during inflammatory bowel diseases (IBD) treatment over 15 years in a high-risk area in Brazil.

Methods: A retrospective study of an IBD patients' database was carried out in a private reference clinic in Brazil. All patients underwent TST testing and chest X-ray prior to treatment, and once a year after starting it. Patients were classified according to the Montreal stratification and risk factors were considered for developing TB.

Results: Among the analyzed factors, age and gender were risk factors for LTB. DC (B2 and P) and UC (E2) patients showed a higher number of LTB cases with statistical significance, what was also observed for adalimumab and infliximab users, compared to other medications, and time of exposure to them favored it significantly. Other factors such as enclosed working environment have been reported as risk.

Conclusion: The risk of biological therapy causing LTB is real, so patients with IBD should be continually monitored. This study reveals that the longer the exposure to anti-TNFs, the greater the risk.

Background: •Rate of infection (tuberculosis) in Brazilians IBD private patients: follow-up 15 years.

Background: •Patients treated with immunosuppressants and/or anti-TNFs have a higher risk of developing opportunistic infections, among them the most common is latent tuberculosis or even active tuberculosis.

Background: •Similar risks may be noted in patients with inflammatory bowel diseases (IBDs).

Background: •This study reveals that the longer the exposure to anti-TNFs, the greater the risk for de IBD patients.

Background: •The study demonstrated the importance of monitoring these patients permanently and continuously.

Download full-text PDF

Source
http://dx.doi.org/10.1590/S0004-2803.24612023-148DOI Listing

Publication Analysis

Top Keywords

infection tuberculosis
8
tuberculosis brazilians
8
brazilians ibd
8
ibd private
8
patients
8
private patients
8
patients follow-up
8
latent tuberculosis
8
risk biological
8
biological therapy
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!